These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


429 related items for PubMed ID: 16481075

  • 1. Anti-CD3 single-chain Fv/interleukin-18 fusion DNA induces anti-mycobacterial resistance via efficient interferon-gamma production in BALB/c mice infected with Mycobacterium avium.
    Kim SH, Cho D, Kim TS.
    Vaccine; 2006 Apr 12; 24(16):3365-73. PubMed ID: 16481075
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
    Changhong S, Hai Z, Limei W, Jiaze A, Li X, Tingfen Z, Zhikai X, Yong Z.
    Tuberculosis (Edinb); 2009 Jan 12; 89(1):54-61. PubMed ID: 19056317
    [Abstract] [Full Text] [Related]

  • 3. Efficient induction of T helper type 1-mediated immune responses in antigen-primed mice by anti-CD3 single-chain Fv/interleukin-18 fusion DNA.
    Kim EJ, Cho D, Kim TS.
    Immunology; 2004 Jan 12; 111(1):27-34. PubMed ID: 14678196
    [Abstract] [Full Text] [Related]

  • 4. A DNA adjuvant encoding a fusion protein between anti-CD3 single-chain Fv and AIMP1 enhances T helper type 1 cell-mediated immune responses in antigen-sensitized mice.
    Lee BC, O'Sullivan I, Kim E, Park SG, Hwang SY, Cho D, Kim TS.
    Immunology; 2009 Jan 12; 126(1):84-91. PubMed ID: 18547366
    [Abstract] [Full Text] [Related]

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 12; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 6. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 12; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 7. Immunization with a DNA vaccine cocktail induces a Th1 response and protects mice against Mycobacterium avium subsp. paratuberculosis challenge.
    Park SU, Kathaperumal K, McDonough S, Akey B, Huntley J, Bannantine JP, Chang YF.
    Vaccine; 2008 Aug 12; 26(34):4329-37. PubMed ID: 18582521
    [Abstract] [Full Text] [Related]

  • 8. [Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].
    Bai YL, Xue Y, Wang LM, Fan AL, Zhang W, Kang J, He JJ, Xu ZK.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Mar 12; 25(3):211-4. PubMed ID: 19257983
    [Abstract] [Full Text] [Related]

  • 9. Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.
    Wang QM, Kang L, Wang XH.
    Microbiol Immunol; 2009 Jul 12; 53(7):384-90. PubMed ID: 19563397
    [Abstract] [Full Text] [Related]

  • 10. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection.
    Wozniak TM, Ryan AA, Triccas JA, Britton WJ.
    Infect Immun; 2006 Jan 12; 74(1):557-65. PubMed ID: 16369012
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity and protective efficacy of a DNA vaccine encoding the fusion protein of mycobacterium heat shock protein 65 (Hsp65) with human interleukin-2 against Mycobacterium tuberculosis in BALB/c mice.
    Wang LM, Bai YL, Shi CH, Gao H, Xue Y, Jiang H, Xu ZK.
    APMIS; 2008 Dec 12; 116(12):1071-81. PubMed ID: 19133010
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infections.
    Denis M, Ghadirian E.
    J Immunol; 1993 Nov 15; 151(10):5425-30. PubMed ID: 8228235
    [Abstract] [Full Text] [Related]

  • 18. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M, D'Souza S, Adnet PY, Laali R, Jurion F, Palfliet K, Huygen K.
    Vaccine; 2006 Apr 12; 24(16):3353-64. PubMed ID: 16488518
    [Abstract] [Full Text] [Related]

  • 19. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.
    Wu J, Ma H, Qu Q, Zhou WJ, Luo YP, Thangaraj H, Lowrie DB, Fan XY.
    Vaccine; 2011 Oct 13; 29(44):7624-30. PubMed ID: 21856352
    [Abstract] [Full Text] [Related]

  • 20. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
    Young SL, Slobbe L, Wilson R, Buddle BM, de Lisle GW, Buchan GS.
    Infect Immun; 2007 Jun 13; 75(6):2833-40. PubMed ID: 17371857
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.